文献速递技术与安全PETMRCTUS

精准肿瘤学时代的弥漫性大B细胞淋巴瘤:影像学如何发挥作用

Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful.
PubMed 文献 · Korean J Radiol · 2017-01-05

本文综述弥漫性大B细胞淋巴瘤(DLBCL)诊疗中的功能与形态影像学方法,指出PET是指导诊断、分期、疗效评估、复发检测及治疗决策的最重要影像工具,MRI适用于神经系统与肌肉骨骼系统受累并可作为一种无辐射的PET/CT替代选择,CT、超声和常规X线也用于淋巴瘤评估。

要点

  • PET是DLBCL诊断、分期、疗效评估、复发检测和治疗决策中最重要的影像工具。
  • MRI适用于神经系统和肌肉骨骼系统受累评估,并正成为无辐射的PET/CT替代选择。
  • CT、超声和常规X线也用于淋巴瘤的评估。

核心结论

  • PET已成为指导肿瘤科医生进行DLBCL诊断、分期、疗效评估、复发/再发检测和治疗决策的最重要影像工具。
  • MRI对神经系统和肌肉骨骼系统受累有用,并正成为无辐射的PET/CT替代选择。
  • 本文全面综述了DLBCL管理中可用的功能和形态影像学方法。

研究设计与样本

  • 本文为综述,检索范围与纳入文献原文未报告。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has emerged as the most important imaging tool to guide oncologists in the diagnosis, staging, response assessment, relapse/recurrence detection,and therapeutic decision making of DLBCL. Other imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and conventional radiography are also used in the evaluation of lymphoma. MRI is useful for nervous system and musculoskeletal system involvement and is emerging as a radiation free alternative to PET/CT. This article provides a comprehensive review of both the functional and morphological imaging modalities, available in the management of DLBCL.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Shah HJ, Keraliya AR, Jagannathan JP, et al. Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful. Korean J Radiol. 2017. PMID: 28096718. doi:10.3348/kjr.2017.18.1.54

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。